Common Contracts

ASSET PURCHASE AGREEMENT by and between AstraZeneca AB, Aralez Pharmaceuticals Trading DAC and Aralez Pharmaceuticals Inc. (solely for the purposes of Section 9.16 hereof)

Asset Purchase Agreement • January 5th, 2017 • Aralez Pharmaceuticals Inc. • Pharmaceutical preparations • New York

• Contract Type
  Asset Purchase Agreement
• Filed
  January 5th, 2017
• Company
  Aralez Pharmaceuticals Inc.
• Industry
  Pharmaceutical preparations
• Jurisdiction
  New York

ASSET PURCHASE AGREEMENT (this “Agreement”) is made and executed as of October 3, 2016 (the “Execution Date”), by and between AstraZeneca AB, a Swedish corporation (“Seller”), Aralez Pharmaceuticals Trading DAC, an Irish designated activity company (“Buyer”) and, solely for the purposes of Section 9.16 hereof, Aralez Pharmaceuticals Inc., a corporation organized under the laws of British Columbia, Canada (“Guarantor”). Seller and Buyer are sometimes referred to herein individually as a “Party” and collectively as the “Parties.”

ASSET PURCHASE AGREEMENT by and between AstraZeneca AB, Aralez Pharmaceuticals Trading DAC and Aralez Pharmaceuticals Inc. (solely for the purposes of Section 9.16 hereof)

Asset Purchase Agreement • October 7th, 2016 • Aralez Pharmaceuticals Inc. • Pharmaceutical preparations • New York

• Contract Type
  Asset Purchase Agreement
• Filed
  October 7th, 2016
• Company
  Aralez Pharmaceuticals Inc.
• Industry
  Pharmaceutical preparations
• Jurisdiction
  New York

ASSET PURCHASE AGREEMENT (this “Agreement”) is made and executed as of October 3, 2016 (the “Execution Date”), by and between AstraZeneca AB, a Swedish corporation (“Seller”), Aralez Pharmaceuticals Trading DAC, an Irish designated activity company (“Buyer”) and, solely for the purposes of Section 9.16 hereof, Aralez Pharmaceuticals Inc., a corporation organized under the laws of British Columbia, Canada (“Guarantor”). Seller and Buyer are sometimes referred to herein individually as a “Party” and collectively as the “Parties.”